Q32 Bio Inc. (QTTB) Receivables (2018 - 2021)

Q32 Bio has reported Receivables for 4 years, with the latest figure at $100000.0 in Q3 2021.

• On a quarterly basis, Receivables fell 75.0% year-over-year to $100000.0 in Q3 2021; TTM through Sep 2021 was $100000.0, a 75.0% decrease from a year earlier, with the FY2020 full-year figure at $400000.0, changed 0.0% from the prior year.
• Receivables was $100000.0 for Q3 2021 at Q32 Bio, down from $200000.0 in the prior quarter.
• The five-year high for Receivables was $800000.0 in Q4 2018, with the low at $100000.0 in Q3 2021.
• Average Receivables over 4 years is $350000.0, with a median of $350000.0 recorded in 2019.
• The sharpest annual moves came in 2020 and 2021: Receivables soared 100.0% in 2020, then plunged 75.0% in 2021.
• Over 4 years, Receivables stood at $800000.0 in 2018, then slumped by 50.0% to $400000.0 in 2019, then changed by 0.0% to $400000.0 in 2020, then slumped by 75.0% to $100000.0 in 2021.
• The last three Receivables figures came in at $100000.0 (Q3 2021), $200000.0 (Q2 2021), and $300000.0 (Q1 2021), per Business Quant data.